← FDA Drug Approvals (Drugs@FDA)

SPIRONOLACTONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: OXFORD PHARMS · Approved 2006-08-29

Drug application

FDA Application #

ANDA040750

Application type

Abbreviated New Drug Application (Generic)

Brand name

SPIRONOLACTONE

Generic name

SPIRONOLACTONE

Active ingredients

SPIRONOLACTONE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

OXFORD PHARMS

Manufacturer

Oxford Pharmaceuticals, LLC

First approval

2006-08-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown